VYXEOS 100 mg/20mL
(daunorubicin and cytarabine) liposome · INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION · Jazz Pharmaceuticals, Inc.
VYXEOS is a injection, powder, lyophilized, for suspension containing (daunorubicin and cytarabine) liposome at 100 mg/20mL, taken intravenous. Manufactured by Jazz Pharmaceuticals, Inc..
Key Facts
- Brand Name
- VYXEOS
- Generic Name
- (daunorubicin and cytarabine) liposome
- NDC Code (Product)
68727-745- Manufacturer
- Jazz Pharmaceuticals, Inc.
- Strength
- 100 mg/20mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA209401
- Drug Class
- Nucleoside Metabolic Inhibitor [EPC]; Anthracycline Topoisomerase Inhibitor [EPC]
- Marketing Start
- 08/03/2017
Recall History
No Recall HistoryFrequently Asked Questions
What is VYXEOS used for?
VYXEOS contains (daunorubicin and cytarabine) liposome. It is a injection, powder, lyophilized, for suspension taken intravenous. Consult your doctor for specific uses.
Is VYXEOS a controlled substance?
VYXEOS is not classified as a controlled substance by the DEA.
What is the generic name for VYXEOS?
The generic name for VYXEOS is (daunorubicin and cytarabine) liposome. There are no other listed brand versions of (daunorubicin and cytarabine) liposome.
What is the NDC code for VYXEOS 100 mg/20mL?
The NDC (National Drug Code) for VYXEOS 100 mg/20mL is 68727-745, listed by Jazz Pharmaceuticals, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)